Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors.
about
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in miceLocal IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammationOverview of the Pathogenesis of ANCA-Associated VasculitisInflammation in arterial diseasesRare diseases.3: Wegener's granulomatosisPR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitisPathogenesis of ANCA-associated vasculitisWegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunityClinical utility of testing for antineutrophil cytoplasmic antibodies.Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.Pathogenesis of ANCA-associated systemic vasculitis.Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitisPathogenesis of ANCA-associated vasculitis.Immunopathological aspects of systemic vasculitis.Human FcR polymorphism and disease.The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.Monocyte activation in patients with Wegener's granulomatosis.Alpha 1-antitrypsin does not inhibit human monocyte caspase-1Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodiesAlpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.Association of HLA genes with clinical outcomes of ANCA-associated vasculitisEndothelium-neutrophil interactions in ANCA-associated diseasesLeukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with PolyangiitisAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitations.Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Innate immune cells in the pathogenesis of primary systemic vasculitis.FcγR requirements leading to successful immunotherapy.Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.ANCA-Associated Vasculitis Pathogenesis: A Commentary.Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2.Bilateral renal ischemia after kyphoplasty and clodronate treatment: a case report.Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium.
P2860
Q24553315-994CA7B3-30E9-40C0-AE6C-706EAA26B213Q24804307-1190E370-2C6F-428E-9303-381E7EE40A01Q26740456-DD0CE246-0F8A-4406-8C2B-7946E7300A65Q26853576-FABB09A7-4C8C-40F6-A274-150175842FA2Q27477902-008AF195-511F-4655-9BE1-6005EE0DF663Q27489023-05235B8B-4AF6-44A2-A34A-E3EA335C16FCQ28347677-4FDC3CB7-5352-4F92-A52E-40AA340A630CQ28390438-F5C75DFD-4C3D-4CA8-9496-E34220D841F0Q28393433-D3E4407C-7CD2-4A38-B2FD-469677710FBBQ33726350-F8EA49CA-FDE4-4FA0-921E-42C355F26D6EQ33760369-C4F21522-013D-4FD7-88A9-8DB696B531CAQ33843581-9B0E24D6-62B7-4B0E-A18B-2310965AA3A2Q34018969-C2E45052-201F-4055-BE97-7D4883D26A8AQ34296337-D73437DB-EE1A-465F-9FC8-F69F82C3EE30Q34395169-99709A61-B7C6-4692-A7B8-ED3B3C22F519Q34406254-07C747F9-6A6C-4997-8DBB-408EA63AD4AAQ35084923-F400E0CC-34CB-4CC1-A8FE-165B0868764DQ35548500-29A792F4-628E-4A0D-BE27-E24D989092C3Q35556752-6F9BA48D-A4E3-411F-87CF-8C54029A7378Q35609175-0B08D37D-9714-467B-AB26-8DE63253029BQ35824921-C288BF44-AC53-4896-AA98-3FA2FC9B3E03Q36126662-EA02B166-8863-4590-88D2-896D62900D10Q36126939-1F3223D9-A5D6-45CE-BD19-42B2023C0086Q36200937-EEE00012-796C-4C79-BED8-CEB3AE03D864Q36715904-406BB232-7F31-4FBC-851A-C550219D38C6Q36809810-C17133A0-92E8-4E5C-96B4-EC7614294FD8Q37173117-4EC50114-E4BA-4C93-8C0B-A4C5390EE5B8Q37272618-4C7A87C8-F147-4189-A23D-1D2C43DF5962Q37599570-0257362A-6FD3-49CD-AED9-FDE446C2ABBAQ37849354-AE66945E-E70A-4E0B-9E2A-1FE001A6A74CQ38079492-3BF80F04-CEE3-478E-AE96-B3CE7A3CE1A6Q38227267-B9598918-C62D-4195-B8C6-45FF436BE7BDQ38365744-080904A6-D10B-4EC5-A209-4A1B9A31EE81Q38592346-01DDA4BF-C56A-4757-87A6-269A1F5633C1Q38615360-99C45939-C81C-49C5-888D-99B29FFB27E1Q38616743-86A97C86-ED09-4C96-96BF-32D1010A0187Q39210329-862E6362-49CB-4BCF-B293-1349907C0142Q39755699-B81B78E0-8474-479B-8D57-4232B4D03400Q40216697-9991B517-9537-43F0-8527-8CF2779A68A6Q40791441-E4769981-5A80-4A28-96A8-70F1F9D3BD03
P2860
Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@en
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@nl
type
label
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@en
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@nl
prefLabel
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@en
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@nl
P2093
P2860
P356
P1476
Antineutrophil cytoplasmic ant ...... rypsin, and Fcgamma receptors.
@en
P2093
P2860
P304
P356
10.1172/JCI119662
P407
P577
1997-09-01T00:00:00Z